![The Streamers to Watch at the Oscars: Netflix Leads, But Mubi Has Substance [Updated]](https://www.adweek.com/wp-content/uploads/2025/01/how-streamers-stack-oscars-2025.jpg?w=640&h=360&crop=1#)
![Local SEO Checklist for 2025 [+ Free Interactive Template]](https://static.semrush.com/blog/uploads/media/aa/8c/aa8c5dcc490028583c90ca059145182b/923675c4192264960a411e492eb81c0a/local-seo-checklist-sm.png)
![[Expert Panel] Effortless Conversions: Close More Sales With AI Data [Webinar] via @sejournal, @lorenbaker](https://www.searchenginejournal.com/wp-content/uploads/2025/02/featured-759.png)
![What's a Marketing Audit? [+ How To Do One]](https://www.hubspot.com/hubfs/Marketing%20Audit.png)
![2025 CPL and CAC Benchmarks [HubSpot Research]](https://www.hubspot.com/hubfs/cost-per-lead-benchmark-1-20250227-9826989.webp)
![246 TikTok caption ideas [plus free caption generator]](https://blog.hootsuite.com/wp-content/uploads/2024/03/tiktok-caption-ideas.png)
Mounjaro Maker Eli Lilly Swipes at Unapproved GLP-1 Rivals in Oscars Ad
At the 2024 Academy Awards, Eli Lilly, the manufacturer of blockbuster weight loss drugs including Mounjaro and Zepbound, criticized people for taking GLP-1s without an obesity diagnosis. In 2025, the pharma giant is changing tack with an attack on its non-FDA-approved rivals. "Healthy Skepticism," from Wieden+Kennedy, will debut at the 97th Academy Awards on Sunday,...
At the 2024 Academy Awards, Eli Lilly, the manufacturer of blockbuster weight loss drugs including Mounjaro and Zepbound, criticized people for taking GLP-1s without an obesity diagnosis. In 2025, the pharma giant is changing tack with an attack on its non-FDA-approved rivals. "Healthy Skepticism," from Wieden+Kennedy, will debut at the 97th Academy Awards on Sunday,...
